Literature DB >> 6215003

Inhibition of proliferative and suppressor responses in the autologous mixed lymphocyte reaction by serum from patients with systemic lupus erythematosus.

H A Stephens, P Fitzharris, R A Knight, M L Snaith.   

Abstract

Serum from patients with systemic lupus erythematosus (SLE) prevents the proliferative response of normal T cells when stimulated by autologous or allogeneic non-T cells. The abrogation of proliferation in an autologous mixed lymphocyte reaction (AMLR) with SLE serum is associated with a lack of suppressor T cell generation. Fractionation of SLE sera on sucrose gradients reveals an 18-12 S peak of Raji cell binding material. Fractions with an S value of </=12 S show inhibitory activity in an AMLR.

Entities:  

Mesh:

Year:  1982        PMID: 6215003      PMCID: PMC1001030          DOI: 10.1136/ard.41.5.495

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  Specificity and suppressor function of human T cells responsive to autologous non-T cells.

Authors:  T Sakane; I Green
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

2.  Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A.

Authors:  J B Innes; M M Kuntz; Y T Kim; M E Weksler
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

3.  Immune complexes in ovarian cancer.

Authors:  T A Poulton; M E Crowther; F C Hay; L J Nineham
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

4.  Activation of suppressor T cells in human autologous mixed lymphocyte culture.

Authors:  J B Smith; R P Knowlton
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

5.  Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells.

Authors:  T Sakane; A D Steinberg; I Green
Journal:  Arthritis Rheum       Date:  1978 Jul-Aug

6.  Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

7.  Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus.

Authors:  E Scopelitis; J J Biundo; M A Alspaugh
Journal:  Arthritis Rheum       Date:  1980-03

8.  Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies.

Authors:  D A Horwitz; M A Garrett; A H Craig
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

9.  Autologous stimulation of human lymphocyte subpopulation.

Authors:  G Opelz; M Kiuchi; M Takasugi; P I Terasaki
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  Separation of spontaneous-killing effector populations by target preference.

Authors:  R A Knight; P Fitzharris
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

View more
  2 in total

1.  New lymphokines produced by SLE sera stimulated lymphocytes: the PNAF (polymorphonuclear activating factors).

Authors:  M T Labro-Bryskier; C Babin-Chevaye; J Hakim
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

2.  Impaired autologous mixed-lymphocyte reaction of peripheral blood lymphocytes in adult periodontitis.

Authors:  S Kimura; N Fujimoto; H Okada
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.